Charles Schwab Investment Management Inc Chembio Diagnostics, Inc. Transaction History

Charles Schwab Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $120,911 - $236,784	-41,983 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $25,455 - $59,671	-7,487 Reduced 15.13%	41,983 $148,000
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $157,314 - $768,763	49,470 New	49,470 $161,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.